MELBOURNE, Australia, July 18, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and ...

SECAUCUS, NJ / ACCESSWIRE / October 17, 2022 / Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, recently announced the launch of a new obstetrics ...

(RTTNews) - Quest Diagnostics (DGX) announced the launch of a new obstetrics laboratory test panel designed to enable physicians to screen all eligible pregnant people for hepatitis C with other ...

Quest Diagnostics launched an obstetrics test panel for screening pregnant people for hepatitis C. The panel is designed to facilitate easy and reliable screening for hepatitis C with other lab tests ...

New test panel follows a Quest Diagnostics Health Trends® study with the CDC that revealed less than half of pregnant people are screened for hepatitis C as recommended under guidelines SECAUCUS, N.J.